Overexpression of both catalytically active and -inactive cathepsin D by cancer cells enhances apoptosis-dependent chemo-sensitivity

Oncogene

Volumn 25, Issue 13, 2006, Pages 1967-1973

  Beaujouin, M ^a   Baghdiguian, S ^b   Glondu Lassis, M ^a   Berchem, G ^c   Liaudet Coopman, E ^a  

^a INSERM   (France)

^b INSTITUT DES SCIENCES DE L EVOLUTION   (France)

^c LUXEMBOURG INSTITUTE OF HEALTH   (Luxembourg)

Author keywords

Apoptosis; Catalytic activity; Cathepsin D; Chemo cytotoxicity; Etoposide; Protease

Indexed keywords

ANTINEOPLASTIC AGENT; CASPASE 3; CASPASE 9; CATHEPSIN D; CYTOCHROME C; ETOPOSIDE; MUTANT PROTEIN; PEPSTATIN; PROTEINASE INHIBITOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER CELL; CATALYSIS; CHEMOSENSITIVITY; CONTROLLED STUDY; CYTOSOL; CYTOTOXICITY; DRUG RESPONSE; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME LOCALIZATION; ENZYME RELEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; WILD TYPE;

ANIMALIA;

EID: 33645276250     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209221     Document Type: Article

References (37)

1. Berchem G, Glondu M, Gleizes M, Brouillet JP, Vignon F, Garcia M et al. (2002). Oncogene 21: 5951-5955.
2. Bidère N, Lorenzo HK, Carmona S, Laforge M, Harper F, Dumont C et al. (2003). J Biol Chem 278: 31401-31411.
3. Capony F, Morisset M, Barrett AJ, Capony JP, Broquet P, Vignon F et al. (1987). J Cell Biol 104: 253-262.
4. Cirman T, Oresic K, Mazovec GD, Turk V, Reed JC, Myers RM et al. (2004). J Biol Chem 279: 3578-3587.
5. Deiss LP, Galinka H, Berissi H, Cohen O, Kimchi A. (1996). EMBO J 15: 3861-3870.
6. Demoz M, Castino R, Cesaro P, Baccino FM, Bonelli G, Isidoro C. (2002). Biol Chem 383: 1237-1248.
7. Emert-Sedlak L, Shangary S, Rabinovitz A, Miranda MB, Delach SM, Johnson DE. (2005). Mol Cancer Ther 4: 733-742.
8. Ferrandina G, Scambia G, Bardelli F, Benedetti Panici P, Mancuso S, Messori A. (1997). British J Cancer 76: 661-666.
9. Foekens JA, Look MP, Bolt-de Vries J, Meijer-van Gelder ME, van Putten WL, Klijn JG. (1999). British J Cancer 79: 300-307.
10. Garcia M, Derocq D, Pujol P, Rochefort H. (1990). Oncogene 5: 1809-1814.
11. Glondu M, Coopman P, Laurent-Matha V, Garcia M, Rochefort H, Liaudet-Coopman E. (2001). Oncogene 20: 6920-6929.
12. Glondu M, Liaudet-Coopman E, Derocq D, Platet N, Rochefort H, Garcia M. (2002). Oncogene 21: 5127-5134.
13. Gottlieb RA, Nordberg J, Skowronski E, Babior BM. (1996). Proc Natl Acad Sci USA 93: 654-658.
14. Heinrich M, Neumeyer J, Jakob M, Hallas C, Tchikov V, Winoto-Morbach S et al. (2004). Cell Death Differ 11: 550-563.
15. Johansson AC, Steen H, Öllinger K, Roberg K. (2003). Cell Death Differ 10: 1253-1259.
16. Kagedal K, Johansson U, Öllinger K. (2001). FASEB J 15: 1592-1594.
17. Koike M, Nakanishi H, Saftig P, Ezaki J, Isahara K, Ohsawa Y et al. (2000). J Neurosci 20: 6898-6906.
18. Koike M, Shibata M, Ohsawa Y, Nakanishi H, Koga T, Kametaka S et al. (2003). Mol Cell Neurosci 22: 146-161.
19. Laurent-Matha V, Maruani-Herrmann S, Prebois C, Beaujouin M, Glondu M, Noel A et al. (2005). J Cell Biol 168: 489-499.
20. Liaudet E, Garcia M, Rochefort H. (1994). Oncogene 9: 1145-1154.
21. Matsuyama S, Llopis J, Deveraux QL, Tsien RY, Reed JC. (2000). Nat Cell Biol 2: 318-325.
22. Nakanishi H, Zhang J, Koike M, Nishioku T, Okamoto Y, Kominami E et al. (2001). J Neurosci 21: 7526-7533.
23. Öllinger K. (2000). Arch Biochem Biophys 373: 346-351.
24. Reiners Jr JJ, Caruso JA, Mathieu P, Chelladurai B, Yin XM, Kessel D. (2002). Cell Death Differ 9: 934-944.
25. Roberg K. (2001). Lab Invest 81: 149-158.
26. Roberg K, Kagedal K, Öllinger K. (2002). Am J Pathol 161: 89-96.
27. Roberg K, Öllinger K. (1998). Am J Pathol 152: 1151-1156.
28. Rochefort H. (1996). Eur J Cancer 32A: 7-8.
29. Saftig P, Hetman M, Schmahl W, Weber K, Heine L, Mossmann H et al. (1995). EMBO J 14: 3599-3608.
30. Sawada M, Nakashima S, Banno Y, Yamakawa H, Hayashi K, Takenaka K et al. (2000). Cell Death Differ 7: 761-772.
31. Shibata M, Kanamori S, Isahara K, Ohsawa Y, Konishi A, Kametaka S et al. (1998). Biochem Biophys Res Commun 251: 199-203.
32. Takuma K, Kiriu M, Mori K, Lee E, Enomoto R, Baba A et al. (2003). Neurochem Int 42: 153-159.
33. Tardy C, Tyynela J, Hasilik A, Levade T, Andrieu-Abadie N. (2003). Cell Death Differ 10: 1090-1100.
34. Terman A, Neuzil J, Kagedal K, Öllinger K, Brunk UT. (2002). Exp Cell Res 274: 9-15.
35. Werneburg NW, Guicciardi ME, Bronk SF, Gores GJ. (2002). Am J Physiol Gastrointest Liver Physiol 283: G947-G956.
36. Westley BR, May FE. (1996). Eur J Cancer 32A: 15-24.
37. Wu GS, Saftig P, Peters C, El-Deiry WS. (1998). Oncogene 16: 2177-2183.